Skip to content
PubMed This is a summary of 49 peer-reviewed journal articles Updated
Endocrinology

Aromatase Deficiency: A Patient Guide

At a Glance

Aromatase deficiency is a rare genetic condition in which the body makes too little estrogen and builds up androgens. It can affect genital development, puberty, growth, and bone strength, but estrogen replacement can support healthy development and reduce bone risks.

Aromatase deficiency is an exceptionally rare genetic condition that fundamentally changes how the body balances its primary sex hormones. It is caused by mutations in the CYP19A1 gene, which provides instructions for making the aromatase enzyme [1]. This enzyme normally acts as a crucial biological bridge, converting androgens into estrogens. Both of these hormones are naturally present in people of all sexes. When this bridge is missing or broken, the body experiences a simultaneous buildup of androgens and a critical shortage of estrogen, a combination that influences development starting even before birth [2].

The way this hormonal imbalance appears depends significantly on a person’s chromosomal pattern and age, and chromosomes do not determine a person’s identity. For 46,XX individuals, the condition is often discovered at birth due to atypical genital development or during pregnancy if the mother experiences physical changes like severe acne or a deepening voice due to androgen exposure [3]. Later in life, the lack of estrogen typically means that puberty does not start on its own. For 46,XY individuals, the signs are often much more subtle and may not be noticed until adulthood, when a person might realize they are continuing to grow much taller and for much longer than their peers because their bones haven’t received the signal to stop [4].

Beyond the visible signs of puberty and growth, aromatase deficiency has a profound impact on the “silent” systems of the body, most notably the skeleton. Estrogen is a vital architect for bone health in all people; it is responsible for strengthening the bones and eventually closing the growth plates at the end of puberty [1]. Without medical intervention, individuals with this condition often face a lifelong risk of thinning bones (osteoporosis) and persistent growth into their twenties. Fortunately, research has shown that replacing the missing estrogen can effectively support bone strength, manage growth, and allow for a healthy, typical transition through puberty [5].

Navigating a diagnosis of such a rare condition can feel overwhelming, but it is important to remember that the biological mechanism is well-understood. While you may need to work with a specialized team of endocrinologists and geneticists to fine-tune a care plan, the core goal remains consistent: providing the body with the hormones it cannot produce on its own. By focusing on long-term bone health and metabolic balance, individuals and families can move forward with a clear path toward managing the condition and supporting overall well-being [6].

Common questions in this guide

What causes aromatase deficiency?
Aromatase deficiency is caused by mutations in the CYP19A1 gene. The gene normally helps the body make aromatase, an enzyme that converts androgens into estrogens; when the enzyme is missing or does not work properly, estrogen is low and androgens build up.
What signs can aromatase deficiency cause?
In people with a 46,XX chromosome pattern, the condition may be recognized at birth because of atypical genital development. During pregnancy, the mother may develop severe acne or a deeper voice from androgen exposure. In people with a 46,XY chromosome pattern, signs can be subtle and may include unusually tall stature or continued growth into adulthood.
How does aromatase deficiency affect puberty and growth?
Low estrogen can prevent puberty from starting on its own and can delay the signal that closes the growth plates at the ends of the bones. As a result, some people continue growing taller for longer than expected, sometimes into their twenties.
Can estrogen replacement help treat aromatase deficiency?
Yes. Replacing the estrogen the body cannot make can support bone strength, help manage growth, and support a healthy transition through puberty. The treatment plan and monitoring schedule should be tailored by the medical team.
Why is bone health monitoring important with aromatase deficiency?
Estrogen helps strengthen bones in people of all sexes. Without enough estrogen, aromatase deficiency can cause lifelong thinning of the bones and osteoporosis, so long-term bone-health monitoring is an important part of care.
Which specialists help manage aromatase deficiency?
Endocrinologists can help manage hormone replacement, growth, puberty, and bone health. Geneticists can help explain the condition’s relationship to CYP19A1 gene changes, and the broader care team can monitor long-term health.

Get notified when new evidence is published on Aromatase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (6)
  1. 1

    Aromatase deficiency in a male patient - Case report and review of the literature.

    Miedlich SU, Karamooz N, Hammes SR

    Bone 2016; (93()):181-186 doi:10.1016/j.bone.2016.09.024.

    PMID: 27693882
  2. 2

    Aromatase deficiency: A case series of 46, XX Chinese children and a systematic review of the literature.

    Fan L, Zhang B, Li L, Gong C

    Clinical endocrinology 2020; (93(6)):687-695 doi:10.1111/cen.14277.

    PMID: 32623730
  3. 3

    Aromatase Deficiency in Two Siblings with 46,XX Karyotype Raised as Different Genders: A Novel Mutation (p.R115X) in the CYP19A1 Gene

    Özen S, Atik T, Korkmaz Ö, et al.

    Journal of clinical research in pediatric endocrinology 2020; (12(1)):109-112 doi:10.4274/jcrpe.galenos.2019.2018.0198.

    PMID: 30968679
  4. 4

    Bone Disease Associated with Inactivating Aromatase Mutations and its Management.

    Cavati G, Merlotti D, Cardamone P, et al.

    Calcified tissue international 2025; (116(1)):14 doi:10.1007/s00223-024-01330-0.

    PMID: 39751875
  5. 5

    Ovarian and uterine development and hormonal feedback mechanism in a 46 XX patient with CYP19A1 deficiency under low dose estrogen replacement.

    Burckhardt MA, Obmann V, Wolf R, et al.

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2015; (31(5)):349-54 doi:10.3109/09513590.2014.995619.

    PMID: 25585547
  6. 6

    A large cohort of disorders of sex development and their genetic characteristics: 6 novel mutations in known genes.

    Ata A, Özen S, Onay H, et al.

    European journal of medical genetics 2021; (64(3)):104154 doi:10.1016/j.ejmg.2021.104154.

    PMID: 33516834

This page is for informational purposes only and does not constitute medical advice. An endocrinologist and geneticist can interpret your results and tailor hormone replacement and long-term monitoring to your needs.